ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Stock price data as of 11/16/2018
Closing price: 69.65
Support price level: N/A
Resistance price level: $80.78
Relative strength index (14-day RSI) 44.0
Beta 1.37
  • CELG is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • With a -32.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • CELG is one of this month's worst performers with a return of -15.5%, underperforming 90 percent of stocks in the S&P-100.

  • Down 5.9 percent, CELG is one of this week's biggest decliners.

  • The price of this high-beta stock is expected to increase by 1.37% for every 1% increase in the S&P-500.

  • CELG is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 35.4%.

  • Volatility is forecast to fall over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$69.63 $109.41 0.1%
200 day 50 day 20 day 10 day
$85.52 $81.53 $73.50 $72.46
(Annualized standard deviation)
(5 year)
Last month Current estimate Next month forecast
30.4% 33.3% 35.4% 32.2%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 9.6% in the next week.

  • 18.2% in the next month.

  • 57.9% in the next year.